Oral budesonide approved for active Crohn's disease.
Thompson
C A
CA
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019819:Budesonide / Q000008:administration & dosage / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000893:Anti-Inflammatory Agents; D019819:Budesonide